Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.
Labeling: Label Mixup: CARBIDOPA/LEVODOPA, Tablet, 25 mg/250 mg may have potentially been mislabeled as the following drug: DIGOXIN, Tablet, 0.125 mg, NDC 00115981101, Pedigree: AD46426_22, EXP: 5/15/2014.
CARBIDOPA/LEVODOPA, Tablet, 25 mg/250 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00093029401.
What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.
Reason Product mix up: complaint received that sealed medication bottle contained Carbidopa, Levodopa, and Entacapone film-coated tablets (37.5 mg/150…
Reason Packaging defect: observed packaging defect, blister packaging inadequately sealed.
Reason Product Mix-Up: A foreign tablet was found in bottle.
Reason Failed Stability Specifications: confirmed out of specification results obtained during refrigerated material stability testing indicating that drug…
Reason Failed Dissolution Specifications
Tell us which medications you take. If the FDA recalls one, we email you - in plain English, with what to do. Free.